Prescription drugs made in India and China. Contaminated…. Illegal….potentially
dangerous…… but sold to you and your family anyways.
It makes corporations a ton of money. Isn’t that great.
Among the drugs prescribed to Americans, 80 percent are
generic drugs, and 40 percent of drugs are now made overseas in countries such
as China and India where U.S. oversight is weaker. (They meant to say oversight
is non-existent.)
Dinesh Thakur, an American-educated chemical engineer, was
hired by Ranbaxy, back in 2003. He would later become a whistleblower, exposing
massive fraud by the generic pharmaceutical giant, a company that sold
Americans drugs like the generic version of Lipitor. His information led to
Ranbaxy pleading guilty to seven felonies in a U.S. court in May, and pay $500
million in fines and settlements.
"The expectations is the drug's supposed to work as
intended," Thakur said. "What we saw in this particular case is that
trust was broken."
Thakur reported his findings to the Food and Drug
Administration in 2005. Their investigation found Ranbaxy had a
"persistent" "pattern" of submitting "untrue
statements." On at least 15 new generic drug applications, auditors found
more than 1,600 data errors. This meant their drugs were "potentially unsafe
and illegal to sell."
"In
essence, they used the fraud as a competitive advantage to build and grow the
business here in the U.S." (That is what Capitalism is all about…God Bless
America)
"Let's say you're treated with a generic cancer drug and
-- and your cancer -- progresses. Is it because of the drug? Is it because of
the disease process? No one would know.
In 2008, shortly after Ranbaxy came under new ownership, the
FDA blocked 30 Ranbaxy drugs from coming into the United States from two Indian
plants. But the company continued to sell drugs in the U.S. from other Indian
facilities.
Then in 2011, while one arm of the FDA was investigating
Ranbaxy for serious criminal violations, another arm of the FDA was approving
Ranbaxy for the exclusive rights to make the generic version of one of the most
popular pharmaceuticals of all time: Lipitor. That decision by the FDA would
earn the company a reported $600 million in the first six months. (Awesome)
CBS News traveled to India to visit the rural Toansa
facility. Active pharmaceutical ingredients -- the key ingredient that makes a
drug work -- are made there. Despite the manicured grounds and catchy safety
slogans, the facility has run into serious problems with the FDA.
In 2012, Ranbaxy issued a recall after finding glass
particles in raw ingredients for generic Lipitor. Later that year at another
Ranbaxy plant, FDA inspectors found faulty cleaning records and a failure to
investigate problems. (Make sure you take your Lipitor with a large glass of
water….It helps digest the GLASS)
"Ranbaxy is committed to providing high quality
affordable drugs to patients in the U.S." and "will take all measures
to keep our facilities in full compliance to all regulations..." (Clearly)
As for Thakur, his findings led Ranbaxy to plead
guilty to seven felonies. For exposing the company, he was awarded $49 million
in a U.S. court. (Good for him)